SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (1959)10/1/1997 11:03:00 AM
From: JOHN W.   of 6136
 
The simple point is that there is much evidence (recent) that contradicts the UCSF findings. Why are the results so different than what MRK and AGPH have presented? We have been over this before.

Have you seen any evidence that disproves the idea of "eradication" based on a mathematical model presnted previously by Dr. Ho (TIME Man of the Year). I would think that the man in Berlin that has no return of viral load after the combo with Crix, maintains the possibility of eradication.

If the you reject the conclusion of the NIH guidelines, what would you suggest for a treatment approach?

You didn't fully answer the question. True or False. Do you have any financial interest directly or indirectly with AGPH's stock price? You have no financial motivation for spending so much time on this thread?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News